Strategic agreement brings innovative electrotherapy and orthotic solutions to America's veterans, active duty and DoD personnel ALEXANDRIA, Va., June 24,…
The Company built the first proprietary AI Care Copilot for its market-leading platform Phamily© to solve for the clinical and…
Dual-System Agreement Highlights Transition Towards Advanced Bedside NavigationTYLER, Texas--(BUSINESS WIRE)--NanoVibronix, Inc. (NASDAQ: NAOV) (“NanoVibronix” or the “Company”), a medical technology…
NEEDHAM, Mass., June 24, 2025 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical…
Cincinnati Children’s Hospital Medical Center Discusses QUELIMMUNE Therapy Adoption A Father and Patient Describe Their Real-Life Experience with the QUELIMMUNE…
Innovate GBM Community Innovate GBM’s Community Members gather at the NASDAQ Closing Bell Ceremony—united in a mission to bridge the…
Huber brings more than 30 years of experience across multiple sectorsDALLAS, June 24, 2025 (GLOBE NEWSWIRE) -- AMN Healthcare (NYSE:…
Priothera Secures €1.7 million i-Nov Funding by Bpifrance for Rare Blood Cancer Clinical Program Funding to support MOCART, a clinical…
Wald’s history of successfully leading outcomes-focused healthcare organizations aligns with CareMore Health’s provider support and patient care prioritiesCERRITOS, Calif., June…
--During the Maintenance Period of 12 weeks after discontinuing semaglutide (GLP-1 receptor agonist), placebo group regained 43% of body weight…